data_1l6h_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1l6h _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 0.253 . . . . . . . 0 C--O 1.17 -3.117 1 N-CA-C 100.027 -4.064 . . . . 0.0 100.027 . . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 42.2 -154.57 0.13 Allowed Glycine 0 C--N 1.365 2.152 1 O-C-N 131.789 5.681 . . . . 0.0 111.883 163.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.403 ' SG ' ' C ' ' A' ' 35' ' ' CYS . 26.2 p -163.55 35.73 0.09 Allowed 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 108.907 -3.646 . . . . 0.0 107.637 168.24 58.463 164.485 76.802 98.988 2.018 98.863 79.173 69.024 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.61 ' ND2' ' CE2' ' A' ' 36' ' ' PHE . 3.7 m120 -102.36 -34.94 9.0 Favored 'General case' 0 CA--C 1.479 -1.785 0 CA-C-N 112.79 -2.005 . . . . 0.0 111.995 -170.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.1 -12.2 3.24 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 112.073 -2.33 . . . . 0.0 113.652 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.61 -55.43 0.95 Allowed Glycine 0 C--N 1.356 1.678 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.025 169.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -79.86 -59.37 2.76 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 117.186 -1.805 . . . . 0.0 107.811 -172.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.502 ' CG ' HD13 ' A' ' 15' ' ' ILE . 3.1 tm? -48.56 -35.19 12.86 Favored 'General case' 0 C--O 1.209 -1.036 0 CA-C-N 111.582 -2.553 . . . . 0.0 113.359 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.4 m -36.42 -37.9 0.14 Allowed 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.87 -50.77 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.222 170.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.657 ' SG ' ' CD1' ' A' ' 29' ' ' LEU . 32.0 m -67.26 14.04 0.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 174.049 -78.584 55.534 -128.446 108.024 2.035 97.277 -95.479 -175.005 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.4 m -63.66 -23.51 67.41 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 118.381 -1.327 . . . . 0.0 111.237 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.58 -35.68 37.83 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 115.223 -3.37 . . . . 0.0 111.666 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.54 ' CA ' ' HG ' ' A' ' 59' ' ' SER . . . -66.55 -61.68 1.85 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 119.105 -1.038 . . . . 0.0 112.046 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.502 HD13 ' CG ' ' A' ' 8' ' ' LEU . 96.7 mt -68.65 -11.59 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 112.289 -2.232 . . . . 0.0 111.173 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.47 ' HA ' ' HB2' ' A' ' 53' ' ' ASN . . . -111.57 17.78 19.68 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.49 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 66.21 61.28 5.57 Favored Glycine 0 C--N 1.341 0.836 0 C-N-CA 118.737 -1.697 . . . . 0.0 112.02 167.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.41 ' HA3' HH12 ' A' ' 20' ' ' ARG . . . 164.0 31.06 0.02 OUTLIER Glycine 0 CA--C 1.532 1.137 0 C-N-CA 117.815 -2.136 . . . . 0.0 115.075 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HB3' ' CA ' ' A' ' 14' ' ' ALA . . . -63.01 94.35 0.07 Allowed 'General case' 0 C--N 1.35 0.599 0 O-C-N 124.748 0.911 . . . . 0.0 111.401 178.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.433 ' HB2' ' HD3' ' A' ' 21' ' ' PRO . 68.8 mtt85 -111.2 -67.4 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 113.398 -1.728 . . . . 0.0 109.586 176.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' A' ' 20' ' ' ARG . 56.3 Cg_endo -72.21 -19.13 26.3 Favored 'Trans proline' 0 C--N 1.372 1.771 0 CA-C-O 122.99 1.162 . . . . 0.0 111.482 -175.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.61 HG22 ' SG ' ' A' ' 11' ' ' CYS . 34.9 m -66.88 -1.85 4.48 Favored 'General case' 0 C--O 1.211 -0.965 0 CA-C-N 111.526 -2.579 . . . . 0.0 112.54 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.2 -37.45 74.81 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 115.965 -2.294 . . . . 0.0 112.955 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.51 -37.47 77.18 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 123.526 1.631 . . . . 0.0 110.379 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.427 ' O ' HD12 ' A' ' 29' ' ' LEU . 45.6 t -57.98 -39.07 77.29 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 112.184 -2.28 . . . . 0.0 108.985 175.739 -175.005 -95.479 -128.446 97.277 2.035 108.024 55.534 -78.584 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.512 ' O ' HG13 ' A' ' 63' ' ' ILE . 71.3 m -44.77 -66.2 0.43 Allowed 'General case' 0 C--N 1.36 1.029 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.421 -62.627 -44.582 -118.898 100.736 2.041 110.317 5.317 -171.582 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.6 p -52.1 -29.74 23.01 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 116.145 -2.222 . . . . 0.0 114.305 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.4 m -61.82 -43.17 99.38 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.881 0.848 . . . . 0.0 111.223 176.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.657 ' CD1' ' SG ' ' A' ' 11' ' ' CYS . 8.3 mp -66.62 -36.13 81.86 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.384 -1.734 . . . . 0.0 107.817 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.466 ' HB2' ' CD1' ' A' ' 63' ' ' ILE . 53.4 ttp85 -66.12 -21.27 66.34 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 122.911 1.339 . . . . 0.0 110.541 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.38 -19.02 28.71 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 111.363 -2.653 . . . . 0.0 110.836 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.488 ' NE2' ' CE1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -135.89 27.98 3.24 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.922 -178.014 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.497 ' HA ' ' CD1' ' A' ' 36' ' ' PHE 0.286 0.0 OUTLIER -55.0 -21.66 12.7 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 123.579 1.656 . . . . 0.0 110.682 -175.437 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.81 -43.08 70.1 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 115.164 -0.925 . . . . 0.0 113.602 -171.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.403 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 21.3 p -77.22 -17.77 58.22 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 116.192 -2.203 . . . . 0.0 111.883 -178.478 69.024 79.173 76.802 98.863 2.018 98.988 164.485 58.463 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.61 ' CE2' ' ND2' ' A' ' 4' ' ' ASN . 90.7 m-85 -68.97 -14.38 63.01 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 124.741 1.276 . . . . 0.0 110.881 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.476 ' CA ' ' HB2' ' A' ' 68' ' ' CYS . 42.3 t -58.47 -30.29 66.87 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 117.272 -1.771 . . . . 0.0 112.259 168.318 -176.573 92.837 -54.365 103.941 2.046 89.208 173.371 -179.575 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.468 ' HA ' ' CE ' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -74.27 -37.16 63.8 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 116.99 -1.884 . . . . 0.0 108.793 177.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.612 ' CZ ' ' CG2' ' A' ' 49' ' ' VAL . 90.4 t80 -56.99 -41.27 78.11 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 117.496 -1.682 . . . . 0.0 110.949 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.485 ' HB3' ' CA ' ' A' ' 67' ' ' THR 0.276 . . -61.81 -19.36 62.46 Favored 'General case' 0 C--O 1.214 -0.812 0 O-C-N 128.416 3.573 . . . . 0.0 115.363 176.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.468 ' CE ' ' HA ' ' A' ' 38' ' ' GLN . 35.1 mtmt -74.45 -5.14 40.84 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 116.672 -2.011 . . . . 0.0 111.192 175.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.4 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 12.0 m-20 52.7 40.25 0.75 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-N 113.857 -1.52 . . . . 0.0 114.059 174.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 42' ' ' ASP . 41.0 Cg_endo -67.15 -42.18 8.32 Favored 'Trans proline' 0 C--N 1.356 0.965 0 CA-C-O 124.003 1.585 . . . . 0.0 108.98 -172.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -145.01 -3.09 0.78 Allowed 'General case' 0 C--N 1.347 0.474 0 CA-C-N 110.679 -2.964 . . . . 0.0 110.963 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -50.08 -39.47 42.51 Favored 'General case' 0 C--O 1.213 -0.86 0 O-C-N 126.728 2.518 . . . . 0.0 108.604 174.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.497 ' N ' ' CD1' ' A' ' 45' ' ' TYR . . . -75.59 -13.17 83.21 Favored Glycine 0 C--O 1.212 -1.277 0 C-N-CA 116.075 -2.964 . . . . 0.0 111.926 -157.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -85.17 -33.87 22.22 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 111.455 -2.373 . . . . 0.0 111.564 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -86.66 -75.93 0.37 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 111.562 -2.563 . . . . 0.0 110.616 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.612 ' CG2' ' CZ ' ' A' ' 39' ' ' PHE . 77.0 t -40.03 -62.59 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.469 -2.171 0 CA-C-N 109.759 -3.382 . . . . 0.0 109.716 -176.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -91.03 93.39 9.16 Favored 'General case' 0 N--CA 1.402 -2.847 1 CA-C-N 105.634 -5.257 . . . . 0.0 100.267 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -147.5 -82.36 0.01 OUTLIER Pre-proline 0 N--CA 1.41 -2.435 2 C-N-CA 108.972 -5.091 . . . . 0.0 104.524 128.886 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -78.49 -24.74 7.37 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 113.447 -3.902 . . . . 0.0 111.506 -136.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.47 ' HB2' ' HA ' ' A' ' 16' ' ' ALA . 44.0 m-20 -135.15 -33.43 0.91 Allowed 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 116.809 -1.956 . . . . 0.0 109.496 -170.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -41.38 -48.01 3.66 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 126.428 2.33 . . . . 0.0 110.367 170.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 51' ' ' SER . 79.1 mtm180 -32.73 -48.73 0.2 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -112.56 -4.23 14.21 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 112.633 -2.076 . . . . 0.0 113.941 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.86 70.28 0.44 Allowed 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -174.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.488 HG13 ' CD2' ' A' ' 65' ' ' LEU . 40.2 t -63.67 -20.2 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 125.869 1.981 . . . . 0.0 109.365 172.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.54 ' HG ' ' CA ' ' A' ' 14' ' ' ALA 0.271 0.5 OUTLIER 112.04 -112.44 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 128.51 2.724 . . . . 0.0 106.692 172.4 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.592 ' H ' ' CD1' ' A' ' 65' ' ' LEU . 8.6 t 99.27 55.66 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.469 0 C-N-CA 129.886 3.274 . . . . 0.0 111.193 -136.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.509 ' H ' HD11 ' A' ' 65' ' ' LEU . 36.2 t -54.8 -26.94 38.09 Favored 'General case' 0 C--N 1.363 1.192 0 CA-C-O 122.299 1.047 . . . . 0.0 108.195 157.758 -171.582 5.317 -118.898 110.317 2.041 100.736 -44.582 -62.627 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.12 -11.9 60.39 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.729 167.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 26' ' ' CYS . 4.0 mm -88.45 -4.16 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.667 0 CA-C-N 109.864 -3.168 . . . . 0.0 111.565 163.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 143.56 -24.02 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.787 0 O-C-N 128.901 3.876 . . . . 0.0 106.844 122.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.656 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 0.0 OUTLIER 76.66 67.46 0.22 Allowed Pre-proline 0 CA--C 1.484 -1.581 2 N-CA-C 96.728 -5.286 . . . . 0.0 96.728 -147.282 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.605 ' HG2' ' CD2' ' A' ' 36' ' ' PHE . 25.6 Cg_endo -68.27 29.87 0.14 Allowed 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 124.818 3.679 . . . . 0.0 115.209 -159.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.485 ' CA ' ' HB3' ' A' ' 40' ' ' ALA 0.282 21.8 m -42.28 140.72 1.1 Allowed 'General case' 0 N--CA 1.405 -2.697 0 CA-C-N 113.344 -1.753 . . . . 0.0 106.815 157.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.476 ' HB2' ' CA ' ' A' ' 37' ' ' CYS 0.289 53.9 t -85.62 41.68 0.92 Allowed 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 123.233 1.492 . . . . 0.0 112.775 -176.942 -179.575 173.371 -54.365 89.208 2.046 103.941 92.837 -176.573 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.426 ' ND1' ' O ' ' A' ' 67' ' ' THR . 31.6 p-80 . . . . . 0 N--CA 1.422 -1.87 0 CA-C-N 109.023 -3.717 . . . . 0.0 107.511 -173.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.545 ' HB1' ' HG2' ' A' ' 43' ' ' PRO 0.253 . . . . . . . 0 C--O 1.17 -3.117 1 N-CA-C 100.027 -4.064 . . . . 0.0 100.027 . . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 42.2 -154.57 0.13 Allowed Glycine 0 C--N 1.365 2.152 1 O-C-N 131.789 5.681 . . . . 0.0 111.883 163.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.403 ' SG ' ' C ' ' A' ' 35' ' ' CYS . 26.2 p -163.55 35.73 0.09 Allowed 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 108.907 -3.646 . . . . 0.0 107.637 168.24 58.463 164.485 76.802 98.988 2.018 98.863 79.173 69.024 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.651 ' ND2' ' CD1' ' A' ' 39' ' ' PHE . 70.7 m-20 -102.36 -34.94 9.0 Favored 'General case' 0 CA--C 1.479 -1.785 0 CA-C-N 112.79 -2.005 . . . . 0.0 111.995 -170.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.1 -12.2 3.24 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 112.073 -2.33 . . . . 0.0 113.652 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.61 -55.43 0.95 Allowed Glycine 0 C--N 1.356 1.678 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.025 169.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -79.86 -59.37 2.76 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 117.186 -1.805 . . . . 0.0 107.811 -172.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.635 ' CG ' HD12 ' A' ' 15' ' ' ILE . 3.1 tm? -48.56 -35.19 12.86 Favored 'General case' 0 C--O 1.209 -1.036 0 CA-C-N 111.582 -2.553 . . . . 0.0 113.359 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.4 m -36.42 -37.9 0.14 Allowed 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.87 -50.77 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.222 170.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.683 ' HA ' ' CG2' ' A' ' 22' ' ' THR . 32.0 m -67.26 14.04 0.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 174.049 -78.584 55.534 -128.446 108.024 2.035 97.277 -95.479 -175.005 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 85.4 m -63.66 -23.51 67.41 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 118.381 -1.327 . . . . 0.0 111.237 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.58 -35.68 37.83 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 115.223 -3.37 . . . . 0.0 111.666 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.487 ' CA ' ' HB2' ' A' ' 19' ' ' ALA . . . -66.55 -61.68 1.85 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 119.105 -1.038 . . . . 0.0 112.046 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.635 HD12 ' CG ' ' A' ' 8' ' ' LEU . 96.7 mt -68.65 -11.59 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 112.289 -2.232 . . . . 0.0 111.173 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.619 ' HA ' ' HB2' ' A' ' 53' ' ' ASN . . . -111.57 17.78 19.68 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.49 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 66.21 61.28 5.57 Favored Glycine 0 C--N 1.341 0.836 0 C-N-CA 118.737 -1.697 . . . . 0.0 112.02 167.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.487 ' HA3' HH12 ' A' ' 20' ' ' ARG . . . 164.0 31.06 0.02 OUTLIER Glycine 0 CA--C 1.532 1.137 0 C-N-CA 117.815 -2.136 . . . . 0.0 115.075 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.487 ' HB2' ' CA ' ' A' ' 14' ' ' ALA . . . -63.01 94.35 0.07 Allowed 'General case' 0 C--N 1.35 0.599 0 O-C-N 124.748 0.911 . . . . 0.0 111.401 178.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.617 ' HB2' ' HD3' ' A' ' 21' ' ' PRO . 68.8 mtt85 -111.2 -67.4 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 113.398 -1.728 . . . . 0.0 109.586 176.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' A' ' 20' ' ' ARG . 56.3 Cg_endo -72.21 -19.13 26.3 Favored 'Trans proline' 0 C--N 1.372 1.771 0 CA-C-O 122.99 1.162 . . . . 0.0 111.482 -175.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.683 ' CG2' ' HA ' ' A' ' 11' ' ' CYS . 34.9 m -66.88 -1.85 4.48 Favored 'General case' 0 C--O 1.211 -0.965 0 CA-C-N 111.526 -2.579 . . . . 0.0 112.54 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.2 -37.45 74.81 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 115.965 -2.294 . . . . 0.0 112.955 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.51 -37.47 77.18 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 123.526 1.631 . . . . 0.0 110.379 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HB3' HG23 ' A' ' 22' ' ' THR . 45.6 t -57.98 -39.07 77.29 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 112.184 -2.28 . . . . 0.0 108.985 175.739 -175.005 -95.479 -128.446 97.277 2.035 108.024 55.534 -78.584 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.651 ' O ' HG13 ' A' ' 63' ' ' ILE . 71.3 m -44.77 -66.2 0.43 Allowed 'General case' 0 C--N 1.36 1.029 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.421 -62.627 -44.582 -118.898 100.736 2.041 110.317 5.317 -171.582 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.6 p -52.1 -29.74 23.01 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 116.145 -2.222 . . . . 0.0 114.305 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 25' ' ' CYS . 51.4 m -61.82 -43.17 99.38 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.881 0.848 . . . . 0.0 111.223 176.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.657 ' CD1' ' SG ' ' A' ' 11' ' ' CYS . 8.3 mp -66.62 -36.13 81.86 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.384 -1.734 . . . . 0.0 107.817 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.503 ' HB2' ' CD1' ' A' ' 63' ' ' ILE . 53.4 ttp85 -66.12 -21.27 66.34 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 122.911 1.339 . . . . 0.0 110.541 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.38 -19.02 28.71 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 111.363 -2.653 . . . . 0.0 110.836 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.488 ' NE2' ' CE1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -135.89 27.98 3.24 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.922 -178.014 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.57 ' HA ' ' CD1' ' A' ' 36' ' ' PHE 0.286 0.0 OUTLIER -55.0 -21.66 12.7 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 123.579 1.656 . . . . 0.0 110.682 -175.437 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.81 -43.08 70.1 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 115.164 -0.925 . . . . 0.0 113.602 -171.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.403 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 21.3 p -77.22 -17.77 58.22 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 116.192 -2.203 . . . . 0.0 111.883 -178.478 69.024 79.173 76.802 98.863 2.018 98.988 164.485 58.463 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.83 ' CD2' ' HG2' ' A' ' 66' ' ' PRO . 90.7 m-85 -68.97 -14.38 63.01 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 124.741 1.276 . . . . 0.0 110.881 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.834 ' HA ' ' HB2' ' A' ' 68' ' ' CYS . 42.3 t -58.47 -30.29 66.87 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 117.272 -1.771 . . . . 0.0 112.259 168.318 -176.573 92.837 -54.365 103.941 2.046 89.208 173.371 -179.575 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.629 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -74.27 -37.16 63.8 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 116.99 -1.884 . . . . 0.0 108.793 177.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.711 ' CZ ' HG22 ' A' ' 49' ' ' VAL . 90.4 t80 -56.99 -41.27 78.11 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 117.496 -1.682 . . . . 0.0 110.949 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.79 ' HB2' ' HA ' ' A' ' 67' ' ' THR 0.276 . . -61.81 -19.36 62.46 Favored 'General case' 0 C--O 1.214 -0.812 0 O-C-N 128.416 3.573 . . . . 0.0 115.363 176.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.629 ' HE3' ' HA ' ' A' ' 38' ' ' GLN . 35.1 mtmt -74.45 -5.14 40.84 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 116.672 -2.011 . . . . 0.0 111.192 175.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.4 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 12.0 m-20 52.7 40.25 0.75 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-N 113.857 -1.52 . . . . 0.0 114.059 174.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.545 ' HG2' ' HB1' ' A' ' 1' ' ' ALA . 41.0 Cg_endo -67.15 -42.18 8.32 Favored 'Trans proline' 0 C--N 1.356 0.965 0 CA-C-O 124.003 1.585 . . . . 0.0 108.98 -172.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.511 ' HA ' HH11 ' A' ' 47' ' ' ARG . 93.9 mtt180 -145.01 -3.09 0.78 Allowed 'General case' 0 C--N 1.347 0.474 0 CA-C-N 110.679 -2.964 . . . . 0.0 110.963 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.606 ' CE2' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -50.08 -39.47 42.51 Favored 'General case' 0 C--O 1.213 -0.86 0 O-C-N 126.728 2.518 . . . . 0.0 108.604 174.549 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.497 ' N ' ' CD1' ' A' ' 45' ' ' TYR . . . -75.59 -13.17 83.21 Favored Glycine 0 C--O 1.212 -1.277 0 C-N-CA 116.075 -2.964 . . . . 0.0 111.926 -157.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.511 HH11 ' HA ' ' A' ' 44' ' ' ARG . 79.3 mtt85 -85.17 -33.87 22.22 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 111.455 -2.373 . . . . 0.0 111.564 174.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -86.66 -75.93 0.37 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 111.562 -2.563 . . . . 0.0 110.616 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.711 HG22 ' CZ ' ' A' ' 39' ' ' PHE . 77.0 t -40.03 -62.59 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.469 -2.171 0 CA-C-N 109.759 -3.382 . . . . 0.0 109.716 -176.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -91.03 93.39 9.16 Favored 'General case' 0 N--CA 1.402 -2.847 1 CA-C-N 105.634 -5.257 . . . . 0.0 100.267 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.581 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -147.5 -82.36 0.01 OUTLIER Pre-proline 0 N--CA 1.41 -2.435 2 C-N-CA 108.972 -5.091 . . . . 0.0 104.524 128.886 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 51' ' ' SER . 59.1 Cg_endo -78.49 -24.74 7.37 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 113.447 -3.902 . . . . 0.0 111.506 -136.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.619 ' HB2' ' HA ' ' A' ' 16' ' ' ALA . 44.0 m-20 -135.15 -33.43 0.91 Allowed 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 116.809 -1.956 . . . . 0.0 109.496 -170.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.549 ' O ' HG23 ' A' ' 58' ' ' VAL . . . -41.38 -48.01 3.66 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 126.428 2.33 . . . . 0.0 110.367 170.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 51' ' ' SER . 79.1 mtm180 -32.73 -48.73 0.2 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -112.56 -4.23 14.21 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 112.633 -2.076 . . . . 0.0 113.941 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.86 70.28 0.44 Allowed 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -174.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.805 HG12 HD23 ' A' ' 65' ' ' LEU . 40.2 t -63.67 -20.2 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 125.869 1.981 . . . . 0.0 109.365 172.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.519 ' HB3' HD11 ' A' ' 65' ' ' LEU 0.271 0.5 OUTLIER 112.04 -112.44 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 128.51 2.724 . . . . 0.0 106.692 172.4 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.945 ' H ' HD11 ' A' ' 65' ' ' LEU . 8.6 t 99.27 55.66 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.469 0 C-N-CA 129.886 3.274 . . . . 0.0 111.193 -136.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.58 ' H ' HD11 ' A' ' 65' ' ' LEU . 36.2 t -54.8 -26.94 38.09 Favored 'General case' 0 C--N 1.363 1.192 0 CA-C-O 122.299 1.047 . . . . 0.0 108.195 157.758 -171.582 5.317 -118.898 110.317 2.041 100.736 -44.582 -62.627 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.12 -11.9 60.39 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.729 167.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 26' ' ' CYS . 4.0 mm -88.45 -4.16 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.667 0 CA-C-N 109.864 -3.168 . . . . 0.0 111.565 163.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.53 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . . . 143.56 -24.02 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.787 0 O-C-N 128.901 3.876 . . . . 0.0 106.844 122.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.945 HD11 ' H ' ' A' ' 60' ' ' SER . 0.0 OUTLIER 76.66 67.46 0.22 Allowed Pre-proline 0 CA--C 1.484 -1.581 2 N-CA-C 96.728 -5.286 . . . . 0.0 96.728 -147.282 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.83 ' HG2' ' CD2' ' A' ' 36' ' ' PHE . 25.6 Cg_endo -68.27 29.87 0.14 Allowed 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 124.818 3.679 . . . . 0.0 115.209 -159.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.79 ' HA ' ' HB2' ' A' ' 40' ' ' ALA 0.282 21.8 m -42.28 140.72 1.1 Allowed 'General case' 0 N--CA 1.405 -2.697 0 CA-C-N 113.344 -1.753 . . . . 0.0 106.815 157.581 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.834 ' HB2' ' HA ' ' A' ' 37' ' ' CYS 0.289 53.9 t -85.62 41.68 0.92 Allowed 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 123.233 1.492 . . . . 0.0 112.775 -176.942 -179.575 173.371 -54.365 89.208 2.046 103.941 92.837 -176.573 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.438 ' HB3' HG22 ' A' ' 67' ' ' THR . 31.6 p-80 . . . . . 0 N--CA 1.422 -1.87 0 CA-C-N 109.023 -3.717 . . . . 0.0 107.511 -173.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.545 ' HB1' ' HG2' ' A' ' 43' ' ' PRO 0.253 . . . . . . . 0 C--O 1.17 -3.117 1 N-CA-C 100.027 -4.064 . . . . 0.0 100.027 . . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 42.2 -154.57 0.13 Allowed Glycine 0 C--N 1.365 2.152 1 O-C-N 131.789 5.681 . . . . 0.0 111.883 163.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.403 ' SG ' ' C ' ' A' ' 35' ' ' CYS . 26.2 p -163.55 35.73 0.09 Allowed 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 108.907 -3.646 . . . . 0.0 107.637 168.24 58.463 164.485 76.802 98.988 2.018 98.863 79.173 69.024 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.608 ' ND2' ' CE2' ' A' ' 36' ' ' PHE . 3.7 m120 -102.36 -34.94 9.0 Favored 'General case' 0 CA--C 1.479 -1.785 0 CA-C-N 112.79 -2.005 . . . . 0.0 111.995 -170.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.1 -12.2 3.24 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 112.073 -2.33 . . . . 0.0 113.652 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.61 -55.43 0.95 Allowed Glycine 0 C--N 1.356 1.678 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.025 169.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -79.86 -59.37 2.76 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 117.186 -1.805 . . . . 0.0 107.811 -172.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.635 ' CG ' HD12 ' A' ' 15' ' ' ILE . 3.1 tm? -48.56 -35.19 12.86 Favored 'General case' 0 C--O 1.209 -1.036 0 CA-C-N 111.582 -2.553 . . . . 0.0 113.359 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.4 m -36.42 -37.9 0.14 Allowed 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.87 -50.77 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.222 170.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.683 ' HA ' ' CG2' ' A' ' 22' ' ' THR . 32.0 m -67.26 14.04 0.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 174.049 -78.584 55.534 -128.446 108.024 2.035 97.277 -95.479 -175.005 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 85.4 m -63.66 -23.51 67.41 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 118.381 -1.327 . . . . 0.0 111.237 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.58 -35.68 37.83 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 115.223 -3.37 . . . . 0.0 111.666 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.487 ' CA ' ' HB2' ' A' ' 19' ' ' ALA . . . -66.55 -61.68 1.85 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 119.105 -1.038 . . . . 0.0 112.046 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.635 HD12 ' CG ' ' A' ' 8' ' ' LEU . 96.7 mt -68.65 -11.59 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 112.289 -2.232 . . . . 0.0 111.173 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.619 ' HA ' ' HB2' ' A' ' 53' ' ' ASN . . . -111.57 17.78 19.68 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.49 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 66.21 61.28 5.57 Favored Glycine 0 C--N 1.341 0.836 0 C-N-CA 118.737 -1.697 . . . . 0.0 112.02 167.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.487 ' HA3' HH12 ' A' ' 20' ' ' ARG . . . 164.0 31.06 0.02 OUTLIER Glycine 0 CA--C 1.532 1.137 0 C-N-CA 117.815 -2.136 . . . . 0.0 115.075 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.487 ' HB2' ' CA ' ' A' ' 14' ' ' ALA . . . -63.01 94.35 0.07 Allowed 'General case' 0 C--N 1.35 0.599 0 O-C-N 124.748 0.911 . . . . 0.0 111.401 178.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.617 ' HB2' ' HD3' ' A' ' 21' ' ' PRO . 68.8 mtt85 -111.2 -67.4 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 113.398 -1.728 . . . . 0.0 109.586 176.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' A' ' 20' ' ' ARG . 56.3 Cg_endo -72.21 -19.13 26.3 Favored 'Trans proline' 0 C--N 1.372 1.771 0 CA-C-O 122.99 1.162 . . . . 0.0 111.482 -175.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.683 ' CG2' ' HA ' ' A' ' 11' ' ' CYS . 34.9 m -66.88 -1.85 4.48 Favored 'General case' 0 C--O 1.211 -0.965 0 CA-C-N 111.526 -2.579 . . . . 0.0 112.54 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.2 -37.45 74.81 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 115.965 -2.294 . . . . 0.0 112.955 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.51 -37.47 77.18 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 123.526 1.631 . . . . 0.0 110.379 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HB3' HG23 ' A' ' 22' ' ' THR . 45.6 t -57.98 -39.07 77.29 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 112.184 -2.28 . . . . 0.0 108.985 175.739 -175.005 -95.479 -128.446 97.277 2.035 108.024 55.534 -78.584 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.651 ' O ' HG13 ' A' ' 63' ' ' ILE . 71.3 m -44.77 -66.2 0.43 Allowed 'General case' 0 C--N 1.36 1.029 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.421 -62.627 -44.582 -118.898 100.736 2.041 110.317 5.317 -171.582 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.6 p -52.1 -29.74 23.01 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 116.145 -2.222 . . . . 0.0 114.305 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 25' ' ' CYS . 51.4 m -61.82 -43.17 99.38 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.881 0.848 . . . . 0.0 111.223 176.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.657 ' CD1' ' SG ' ' A' ' 11' ' ' CYS . 8.3 mp -66.62 -36.13 81.86 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.384 -1.734 . . . . 0.0 107.817 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.503 ' HB2' ' CD1' ' A' ' 63' ' ' ILE . 53.4 ttp85 -66.12 -21.27 66.34 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 122.911 1.339 . . . . 0.0 110.541 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.38 -19.02 28.71 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 111.363 -2.653 . . . . 0.0 110.836 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.488 ' NE2' ' CE1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -135.89 27.98 3.24 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.922 -178.014 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.57 ' HA ' ' CD1' ' A' ' 36' ' ' PHE 0.286 0.0 OUTLIER -55.0 -21.66 12.7 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 123.579 1.656 . . . . 0.0 110.682 -175.437 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.81 -43.08 70.1 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 115.164 -0.925 . . . . 0.0 113.602 -171.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.403 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 21.3 p -77.22 -17.77 58.22 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 116.192 -2.203 . . . . 0.0 111.883 -178.478 69.024 79.173 76.802 98.863 2.018 98.988 164.485 58.463 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.83 ' CD2' ' HG2' ' A' ' 66' ' ' PRO . 90.7 m-85 -68.97 -14.38 63.01 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 124.741 1.276 . . . . 0.0 110.881 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.834 ' HA ' ' HB2' ' A' ' 68' ' ' CYS . 42.3 t -58.47 -30.29 66.87 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 117.272 -1.771 . . . . 0.0 112.259 168.318 -176.573 92.837 -54.365 103.941 2.046 89.208 173.371 -179.575 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.629 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -74.27 -37.16 63.8 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 116.99 -1.884 . . . . 0.0 108.793 177.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.711 ' CZ ' HG22 ' A' ' 49' ' ' VAL . 90.4 t80 -56.99 -41.27 78.11 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 117.496 -1.682 . . . . 0.0 110.949 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.79 ' HB2' ' HA ' ' A' ' 67' ' ' THR 0.276 . . -61.81 -19.36 62.46 Favored 'General case' 0 C--O 1.214 -0.812 0 O-C-N 128.416 3.573 . . . . 0.0 115.363 176.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.629 ' HE3' ' HA ' ' A' ' 38' ' ' GLN . 35.1 mtmt -74.45 -5.14 40.84 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 116.672 -2.011 . . . . 0.0 111.192 175.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.4 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 12.0 m-20 52.7 40.25 0.75 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-N 113.857 -1.52 . . . . 0.0 114.059 174.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.545 ' HG2' ' HB1' ' A' ' 1' ' ' ALA . 41.0 Cg_endo -67.15 -42.18 8.32 Favored 'Trans proline' 0 C--N 1.356 0.965 0 CA-C-O 124.003 1.585 . . . . 0.0 108.98 -172.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.511 ' HA ' HH11 ' A' ' 47' ' ' ARG . 93.9 mtt180 -145.01 -3.09 0.78 Allowed 'General case' 0 C--N 1.347 0.474 0 CA-C-N 110.679 -2.964 . . . . 0.0 110.963 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.606 ' CE2' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -50.08 -39.47 42.51 Favored 'General case' 0 C--O 1.213 -0.86 0 O-C-N 126.728 2.518 . . . . 0.0 108.604 174.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.497 ' N ' ' CD1' ' A' ' 45' ' ' TYR . . . -75.59 -13.17 83.21 Favored Glycine 0 C--O 1.212 -1.277 0 C-N-CA 116.075 -2.964 . . . . 0.0 111.926 -157.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.511 HH11 ' HA ' ' A' ' 44' ' ' ARG . 79.3 mtt85 -85.17 -33.87 22.22 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 111.455 -2.373 . . . . 0.0 111.564 174.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -86.66 -75.93 0.37 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 111.562 -2.563 . . . . 0.0 110.616 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.711 HG22 ' CZ ' ' A' ' 39' ' ' PHE . 77.0 t -40.03 -62.59 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.469 -2.171 0 CA-C-N 109.759 -3.382 . . . . 0.0 109.716 -176.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -91.03 93.39 9.16 Favored 'General case' 0 N--CA 1.402 -2.847 1 CA-C-N 105.634 -5.257 . . . . 0.0 100.267 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.581 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -147.5 -82.36 0.01 OUTLIER Pre-proline 0 N--CA 1.41 -2.435 2 C-N-CA 108.972 -5.091 . . . . 0.0 104.524 128.886 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 51' ' ' SER . 59.1 Cg_endo -78.49 -24.74 7.37 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 113.447 -3.902 . . . . 0.0 111.506 -136.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.619 ' HB2' ' HA ' ' A' ' 16' ' ' ALA . 44.0 m-20 -135.15 -33.43 0.91 Allowed 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 116.809 -1.956 . . . . 0.0 109.496 -170.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.549 ' O ' HG23 ' A' ' 58' ' ' VAL . . . -41.38 -48.01 3.66 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 126.428 2.33 . . . . 0.0 110.367 170.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 51' ' ' SER . 79.1 mtm180 -32.73 -48.73 0.2 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -112.56 -4.23 14.21 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 112.633 -2.076 . . . . 0.0 113.941 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.86 70.28 0.44 Allowed 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -174.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.805 HG12 HD23 ' A' ' 65' ' ' LEU . 40.2 t -63.67 -20.2 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 125.869 1.981 . . . . 0.0 109.365 172.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.519 ' HB3' HD11 ' A' ' 65' ' ' LEU 0.271 0.5 OUTLIER 112.04 -112.44 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 128.51 2.724 . . . . 0.0 106.692 172.4 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.945 ' H ' HD11 ' A' ' 65' ' ' LEU . 8.6 t 99.27 55.66 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.469 0 C-N-CA 129.886 3.274 . . . . 0.0 111.193 -136.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.58 ' H ' HD11 ' A' ' 65' ' ' LEU . 36.2 t -54.8 -26.94 38.09 Favored 'General case' 0 C--N 1.363 1.192 0 CA-C-O 122.299 1.047 . . . . 0.0 108.195 157.758 -171.582 5.317 -118.898 110.317 2.041 100.736 -44.582 -62.627 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.12 -11.9 60.39 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.729 167.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 26' ' ' CYS . 4.0 mm -88.45 -4.16 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.667 0 CA-C-N 109.864 -3.168 . . . . 0.0 111.565 163.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.53 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . . . 143.56 -24.02 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.787 0 O-C-N 128.901 3.876 . . . . 0.0 106.844 122.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.945 HD11 ' H ' ' A' ' 60' ' ' SER . 0.0 OUTLIER 76.66 67.46 0.22 Allowed Pre-proline 0 CA--C 1.484 -1.581 2 N-CA-C 96.728 -5.286 . . . . 0.0 96.728 -147.282 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.83 ' HG2' ' CD2' ' A' ' 36' ' ' PHE . 25.6 Cg_endo -68.27 29.87 0.14 Allowed 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 124.818 3.679 . . . . 0.0 115.209 -159.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.79 ' HA ' ' HB2' ' A' ' 40' ' ' ALA 0.282 21.8 m -42.28 140.72 1.1 Allowed 'General case' 0 N--CA 1.405 -2.697 0 CA-C-N 113.344 -1.753 . . . . 0.0 106.815 157.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.834 ' HB2' ' HA ' ' A' ' 37' ' ' CYS 0.289 53.9 t -85.62 41.68 0.92 Allowed 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 123.233 1.492 . . . . 0.0 112.775 -176.942 -179.575 173.371 -54.365 89.208 2.046 103.941 92.837 -176.573 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.438 ' HB3' HG22 ' A' ' 67' ' ' THR . 31.6 p-80 . . . . . 0 N--CA 1.422 -1.87 0 CA-C-N 109.023 -3.717 . . . . 0.0 107.511 -173.182 . . . . . . . . 1 1 . 1 stop_ save_